Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nathalie Perez Staub"'
Autor:
Delphine Loirat, Marie Duboys de la barre, Jean-Christophe Thery, Ioana Hrab, Christelle Jouannaud, Jean-Loup Mouysset, Laura Salabert, Pauline Soibinet, Audrey Mailliez, Romain Valery, Anne Creisson, Cristian Villanueva, Nadine Dohollou, Jean-david Fumet, Thomas grellety, Nathalie Perez-staub, Emma Lachaier, Aurore Iltis-roux, Miguel delbado, Abeer Najem, Romuald Le Scodan, Elsa Curtit, kais aldabbagh, Pascal Pujol, thibault DE LA MOTTE ROUGE
Publikováno v:
Cancer Research. 83:P4-01
Background: Talazoparib (TALA) is a highly potent, dual-mechanism PARP inhibitor that has demonstrated clinical benefit in EMBRACA Phase III trial for patients with germline BRCA1/2 mutated locally advanced or metastatic HER2- breast cancer. Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a596f8224ee2027f488b49261ea03bf
https://doi.org/10.1158/1538-7445.sabcs22-p4-01-20
https://doi.org/10.1158/1538-7445.sabcs22-p4-01-20
Autor:
Ida Iurisci, Annette K. Larsen, Nathalie Perez Staub, Arnaud Saget, Benoist Chibaudel, Perrine Goyer, Aimery de Gramont, Linda Dainese, Hubert Richa, Laurence Heuls, Helene Marijon
Publikováno v:
Biomedical Journal of Scientific & Technical Research. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::983b36c225f06d6a15c70a92e6fa5b59
https://doi.org/10.26717/bjstr.2018.06.001409
https://doi.org/10.26717/bjstr.2018.06.001409